Company Hopes Test Will Revolutionize Autism Diagnosis and Treatment

MADISON, Wis. — Madison stem cell research company Stemina Biomarker Discovery plans to introduce a metabolism-based autism blood test to the public in 2017.

“What we hope this will do is revolutionize the way we diagnose and treat autism, so that we can both diagnose sooner and focus treatment,” Stemina CEO Beth Donley said. “So that parents aren't going to the Internet unarmed with diagnosis, wondering ‘What thing should I try first with my child and how do we get there?’”